|
|
|
|
| LEADER |
01877nam a2200253 u 4500 |
| 001 |
EB002001569 |
| 003 |
EBX01000000000000001164470 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
210907 r ||| eng |
| 100 |
1 |
|
|a Biesecker, Barbara
|
| 245 |
0 |
0 |
|a Making clinical trials more patient-centered using digital interactive e-consent tools
|h Elektronische Ressource
|c Barbara Biesecker, Melissa Raspa, Douglas Rupert, Rebecca Moultrie, Robert Furberg, and Lauren A. McCormack
|
| 260 |
|
|
|a Research Triangle Park, NC
|b RTI International
|c October 2019, 2019
|
| 300 |
|
|
|a 1 PDF file (5 pages)
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a Occasional paper
|
| 500 |
|
|
|a "RTI Press publication OP-0063-1910."
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK558162
|3 Volltext
|
| 082 |
0 |
|
|a 140
|
| 082 |
0 |
|
|a 170
|
| 082 |
0 |
|
|a 380
|
| 520 |
|
|
|a Research participants are required give their consent to participate in clinical trials and non-exempt government-funded studies. The goal is to facilitate participant understanding of the intent of the research, its voluntary nature, and the potential benefits and harms. Ideally, participants make an informed choice whether to participate; one that is based on having sufficient relevant knowledge and that is consistent with their values and preferences. Achieving this objective can be challenging and as such; many scholars have declared the consent process flawed or "broken." Moreover, clinical trials are complex studies, and compelling evidence suggests that current consent processes are inadequate in achieving informed choice. E-consent offers a dynamic, engaging consent delivery mode that can effectively support making informed decisions about whether to participate in a trial
|